Judge tosses lawsuit alleging double-billing by Epic: ‘Based on pure speculation’

A federal judge in Florida has tossed out a lawsuit against Epic Systems, saying the plaintiff “parroted” the language of the False Claims Act without offering support for her claim that the company’s billing system software double-billed Medicare and Medicaid for anesthesia services.

The suit had been filed by Geraldine Petrowski, a former supervisor of physician coding at WakeMed Health in Raleigh, North Carolina, in 2015 and was unsealed in November 2017. She alleged Epic’s Resolute Billing Charge Capture system, had a default setting to charge for anesthesia services for both the “base units” to be reported on the claim form—which CMS had said shouldn’t be included—as well as the actual time a physician had taken on the procedure.

In dismissing the complaint, U.S. District Judge James Moody Jr. said Petrowski failed to make credible allegations—like offering examples of a false claim submitted to Medicare or how Epic supposedly misrepresented the software’s capabilities. One of her exhibits was just a list of hospitals and health systems which use the software.

“Petrowski alleges only that Epic’s software could be used in such a way that would allow its hospital customers to generate bills that cause the Medicare program to double pay for certain aspects of professional anesthesia services,” Moody wrote. “This is woefully deficient because it is based on pure speculation.”

Epic had denied the allegations went the suit was unsealed, pointing out the U.S. Department of Justice had declined to join the case.

“As we previously stated, the plaintiff’s assertions represented a fundamental misunderstanding of how claims software works,” Epic spokesperson Meghan Roh said in a statement to HealthExec. “We are pleased the court dismissed this case.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.